The HIV-1 protease plays an essential role in the replication cycle of HIV-1; therefore there is a direct need to develop novel inhibitors of the HIV-1 protease, which can cease the viral replication. The present study targets the discovery of potential inhibitors of HIV-1 protease from a set of phytochemicals. From 2505 phytochemicals, 108 compounds were docked, after screening, with the HIV-1 protease to analyze their inhibitory potential against the protease. DFT analysis was also conducted to study the reactivity of strongly docked compounds. Out of 108 phytochemicals, 38 compounds showed binding affinity greater than the desired threshold. Reactivity of these 38 inhibitors was also high as compared to other compounds, based on...
We have developed a novel plasmid-based, quantitative, in vitro screen to test the protease-inhibiti...
Objective: The reason for the failure of most of the anti-HIV drugs are their poor pharmacokinetics,...
HIV-1 protease is one of the major antiviral targets in the treatment of patients infected with HIV-...
The life-threatening infections and pandemic spread of Human Immunodeficiency virus-1 (HIV-1), the e...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemistry, 2019Cataloged from P...
The human immunodeficiency virus type 1 (HIV-1) has continued to be a global concern. With the new H...
We can devise a drug (inhibitor) to restrain the activity of gene. As a gene engenders protein/enzym...
Abstract Only a few medications are approved for the treatment of infected patients, despite the pr...
Under the selective pressure of protease inhibitor therapy, patients infected with human immunodefic...
Abstract Background: Because of the reported high ability of virulence and medicinal resistance of ...
This study has focused on the synthesis of truncated analogues of the hydroxyethylene dipeptide isos...
Thesis (M.Sc. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2005.The acq...
AbstractBackground: Effective HIV protease inhibitors must combine potency towards wild-type and mut...
Cheminformatic approaches have been employed to optimize the bis-coumarin scaffold identified by Ony...
Most drugs clinically used to suppress replication of HIV, the virus that causes AIDS, are nucleosid...
We have developed a novel plasmid-based, quantitative, in vitro screen to test the protease-inhibiti...
Objective: The reason for the failure of most of the anti-HIV drugs are their poor pharmacokinetics,...
HIV-1 protease is one of the major antiviral targets in the treatment of patients infected with HIV-...
The life-threatening infections and pandemic spread of Human Immunodeficiency virus-1 (HIV-1), the e...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemistry, 2019Cataloged from P...
The human immunodeficiency virus type 1 (HIV-1) has continued to be a global concern. With the new H...
We can devise a drug (inhibitor) to restrain the activity of gene. As a gene engenders protein/enzym...
Abstract Only a few medications are approved for the treatment of infected patients, despite the pr...
Under the selective pressure of protease inhibitor therapy, patients infected with human immunodefic...
Abstract Background: Because of the reported high ability of virulence and medicinal resistance of ...
This study has focused on the synthesis of truncated analogues of the hydroxyethylene dipeptide isos...
Thesis (M.Sc. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2005.The acq...
AbstractBackground: Effective HIV protease inhibitors must combine potency towards wild-type and mut...
Cheminformatic approaches have been employed to optimize the bis-coumarin scaffold identified by Ony...
Most drugs clinically used to suppress replication of HIV, the virus that causes AIDS, are nucleosid...
We have developed a novel plasmid-based, quantitative, in vitro screen to test the protease-inhibiti...
Objective: The reason for the failure of most of the anti-HIV drugs are their poor pharmacokinetics,...
HIV-1 protease is one of the major antiviral targets in the treatment of patients infected with HIV-...